@CKD_ce Profile picture
May 17, 2022 36 tweets 43 min read Read on X
1) Welcome to our #accredited #tweetorial on optimal mgt of #hyperkalemia in the patient with #CKD. Earn 0.5h #CME/CE credit by following this thread. I am Sourabh Sharma MD DNB FASN 🇮🇳 @iamnephrologist & u have found the ONLY source for CE credit delivered entirely on Twitter!
2) This program is supported by educational grants from AstraZeneca and Bayer & is intended for #healthcare providers. See faculty disclosures ckd-ce.com/disclosures/. Educational credit for #physicians #physicianassociate #nurses #nursepractitioners #pharmacists 🇺🇸🇨🇦🇪🇺🇬🇧
3) Potassium was first isolated by Humphry Davy in 1807 by electrolysis (Coined word from “Potash” [Dutch]). The periodic table symbol K was derived from kali (alkali) [Arabic].
en.wikipedia.org/wiki/Potassium
#NephroNotes #NephPearls #FOAMed #MedEd @MedTweetorials #CardioTwitter
4) Re potassium #homeostasis: 98% of the body's K lies in intracellular space➡️ helping determine resting membrane potential & intracellular electronegativity.
10% of K secretion is via the colon (↑significantly in advancing CKD) 🔓kidney360.asnjournals.org/content/1/1/65 #NephroNotes
5) There is debate abt the definition of hyperK (>5? >5.5?), but it is classified by serum K & ECG. Mortality risk is independent of symptoms, but not ECG findings, as bradycardia/junctional rhythm/QRS widening→Poor outcome.
🔓kidney-international.org/article/S0085-…
🔓mayoclinicproceedings.org/article/S0025-…
6) Arrhythmia in Hyperkalemia
Moderate HyperK: Fast Na channel activation; ↑excitability/conduction velocity: Peaked T
Severe HyperK: Fast Na channel inactivation/Inwardly rectifying K channel activation: Wide QRS/Conduction block
🔓academic.oup.com/ndt/article/34…
7) There are multiple causes of #hyperkalemia:
a. Pseudohyperkalemia
b. Redistribution
c. Excess intake
d. Impaired renal K secretion
In #CKD, relative risk of hyperK approximately doubles for every⬇️in eGFR of 15 mL/min
🔓ccjm.org/content/84/12/…
#NephroNotes #NephPearls #MedEd
8) Because it may be unexpected, we must be especially cautious of drug-induced hyperkalemia
🔓academic.oup.com/ndt/article/34…
#NephroNotes #NephPearls #FOAMed #MedEd
9) So let's focus on #hyperkalemia in #CKD ➡️adverse outcomes, as it restricts RAASi & MRA usage. #CKD patients have multiple risk factors for hyperkalemia. For those on dialysis, long interdialytic gap ⬆️hyperkalemia chances
nature.com/articles/nrnep…
#NephroNotes #NephPearls
10) This table is a nice summary of causes and treatment of hyperkalemia across continuum of kidney function, from 🔓cjasn.asnjournals.org/content/13/1/1…
#NephroNotes #NephPearls #FOAMed #MedEd
11) A low-K diet is generally recommended in advanced #CKD, but @goKDIGO suggests interventional trials to determine optimal recommendations, as there is no direct evidence to link dietary K & serum K, and the benefits of K can’t be ignored
🔓kidney360.asnjournals.org/content/1/1/65
#NephroNotes
12) Guidelines for use of #RAAS inhibitors are intertwined with K homeostasis. Strive for maximum tolerated RAASi therapy! Treat hyperkalemia & reinitiate RAASi after resolution, then reassess K level within 1 wk
🔓ccjm.org/content/84/12/…
🔓mayoclinicproceedings.org/article/S0025-…
#NephPearls
13) Patient education is🔑:
@NKF recommends⬆️patient awareness of hyperK
👉Educational tools
👉Lifestyle change
👉Dietary modification
👉Campaigns
👉Involve allied healthcare professionals
Hyperkalemia is often asymptomatic; regular K monitoring needed!
🔓kidney.org/atoz/content/h…
14) The National Institute for Health and Care Excellence #NICE offers a systematic Treatment Approach to #hyperkalemia
👉Account for clinical priorities
👉↓variability
👉improve pt outcome
👉↓adverse events
🔓ukkidney.org/sites/renal.or…
#NephroNotes #NephPearls #FOAMed #MedEd
15) So when hyperK happens, how is it treated? Acutely:
👉IV calcium ↓cardiac membrane excitation (1-3 min)
👉Insulin/glucose & β agonist redistribute K to ICS (30-60 min) but not ↓total body K
👉β Agonists: short duration of effect (2-4hrs)
👉Sodium bicarbonate ↑K elimination
16) #Hemodialysis increases total K elimination & is used for resistant acute hyperkalemia
🔓mayoclinicproceedings.org/article/S0025-…
#NephroNotes #NephPearls #FOAMed #MedEd
17) So among acute treatment options, different medications have rapid, intermediate or delayed onset of action
Rapidly & intermediately acting medications are required in acute hyperkalemia management
🔓pubmed.ncbi.nlm.nih.gov/23882341/
#NephroNotes #NephPearls #FOAMed #MedEd
18) So let's look at drug administration & safety of different emergency use medications
IV Calcium preparation
👉Calcium Chloride
👉Calcium Gluconate
🔓ukkidney.org/sites/renal.or…
#NephroNotes #NephPearls
19) Insulin/Glucose Infusion: Consider
👉Drug administration & safety
👉Alternative glucose preparations
🔓ukkidney.org/sites/renal.or…
#NephroNotes #NephPearls #FOAMed #MedEd
20) #Salbutamol: Drug administration & safety
Effective but more likely to produce side effects
🔓ukkidney.org/sites/renal.or…
#NephroNotes #NephPearls #FOAMed #MedEd
21) So now let's look at oral potassium binders, which are more useful in chronic mgt & can help facilitate #RAASi optimization. Which of the following binders has the most rapid onset of action after oral administration?
22) Mark your best response & return TOMORROW for the correct answer and the remainder of this program! 👏to @sibgokcay @dr_nikhilshah @kdjhaveri @proychaudhuryMD @divyaa24 @arvindcanchi @priti899 @vjha126 @nephprasad @Gawad_Nephro @SmeetaSinha @Priyasinghbmc @Joe_Vassalotti
23) Welcome back! I am @iamnephrologist and we're talking about #hyperkalemia in #CKD and what to do about it! You are earning🆓CE/#CME, #physicians #physicianassistants #nursepractitioners #pharmacists #nurses. Shout-outs to @vipvargh @gudnephron @SwastiThinks @docanjuyadav
24) We were about to start talking about the oral K binders. (BTW earn MORE CE/#CME on this topic at cardiometabolic-ce.com/category/hyper…) Yes, prune juice is a K binder, but it's not quick, & it may make a bigger mess than Na polystyrene sulfonate. So the correct answer was D. More to learn!
25) So these oral potassium binders are to be considered in chronic #hyperkalemia despite diuretic therapy/corrected metabolic acidosis. They potentially allow continuation/optimization of RAASi/ MRA
🔓mayoclinicproceedings.org/article/S0025-…
#NephroNotes #NephPearls #FOAMed #MedEd
26) So in the K binder🌎, there is old and there is new.
New binders have opened new horizons for treatment & prevention of hyperkalemia
🔓ukkidney.org/sites/renal.or…
#NephroNotes #NephPearls #FOAMed #MedEd
27) Start w/the old. Sodium/Calcium Polysterene Sulfonate clinical studies:
👉Limited evidence for effectiveness/safety
👉With sorbitol, can cause colonic necrosis
👉Nonselective for K, with affinity for Ca/Mg ions
👉Caution: Na & volume overload
🔓frontiersin.org/articles/10.33…
28) And then the new. First, #patiromer sorbitex calcium clinical studies:
👉Efficacy established in randomized, placebo-controlled, phase 2 and 3 trials (CKD/ HF/RAASi)
👉Onset of action~ 7 hours
👉No serious AEs
🔓frontiersin.org/articles/10.33…
#NephPearls #FOAMed #MedEd
29) Sodium Zirconium Cyclosilicate (#SZC) clinical studies:
👉Efficacy & safety established in Ph 2 & 3 trials (#CKD/#HF/#DM/#RAASi)
👉assoc'd w/ ↑Bicarbonate
👉High selectivity for K & ammonium ions
👉fast onset, starts in small bowel
👉No serious AEs
🔓frontiersin.org/articles/10.33…
30) Summary: Clinical trials of oral potassium binders
🔓ukkidney.org/sites/renal.or…
#NephroNotes #NephPearls #FOAMed #MedEd
31) Treatment of #Hyperkalemia in #hemodialysis patients:
👉Hyperkalaemia contributes to mortality in HD (3-5% deaths)
👉K ⤴️is most common immediately post 3-day weekend break
👉Adjust dialysate K as per 🔓ukkidney.org/sites/renal.or…
32) In summary, the treatment of hyperkalemia is likely to evolve in the coming years with the availability of novel drugs & the development of new strategies to improve safety. Clinical decisions on when to treat & how aggressively to treat require a pt-centered approach ...
33) ... guided by the clinical setting and rate of change in serum K+ level. Patients with moderate levels of hyperkalemia pose the greatest dilemma, especially when acuity is low, but warrant intervention to avoid deterioration.
34) Severe hyperkalemia risks arrhythmias & cardiac arrest, therefore prompt recognition and intervention is required. How big a problem is it? In-hospital mortality is significantly higher in patients w/ hyperkalaemia (X%) hypokalaemia (Y%) vs normokalaemia (Z%). What are X,Y,Z?
35) Per NICE guidelines, the correct answer is B, more exactly hyperkalemia (18.1%) compared to those with hypokalemia (5.0%) or normokalemia (3.9%). Pts with severe hyperK (> 6.5 mmol/l) are most at risk & in one report (🔓pubmed.ncbi.nlm.nih.gov/23171442/ ), hospital mortality was 30.7%.
36) And that's it! You made it! Go grab your CE/#CME certificate at ckd-ce.com/foundations_hy…. I am @iamnephrologist and I hope you'll FOLLOW @ckd_ce AND @cardiomet_ce for more #accredited #tweetorials from expert authors all over the 🌎🌍🌏!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with @CKD_ce

@CKD_ce Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ckd_ce

Oct 9
1) Welcome to a new #accredited #tweetorial from the partnership of @ckd_ce and @ISNeducation. This tweetorial has been prepared by @Dilushiwijay and provides 0.75hr CE/#CME. Image
2) Statement of accreditation and author disclosures can be found at . No industry funding was provided for this program, which is accredited by @academiccme.
So . . .
How much do you know about #IgAN? 🤔ckd-ce.com/disclosures/
3) Which of these statements about #IgAN is FALSE?
A. It is the most common primary glomerulonephritis
B. It is benign
C. It has a heterogenous presentation
D. It is characterized by dominant or co-dominant IgA staining on biopsy
Read 51 tweets
Feb 21, 2023
1) Welcome to this #accredited #tweetorial on genetic testing in the evaluation of patients with cystic kidney disease. #Kidney #cysts are a frequent finding, ranging from simple cysts to suspected or confirmed #ADPKD.
Expert author @dguerrot of @CHURouen 🇫🇷 leads us!
2) This program is supported by an educational grant from Otsuka Pharmaceuticals & is intended for #HCPs. #Physicians #Physicianassociates #nurses #nursepractioners #pharmacists 🇺🇸🇨🇦🇪🇺🇬🇧 earn CE/#CME credit. Statement of accreditation & faculty disclosures ckd-ce.com/disclosures
3a) Fortuitous discovery of non-malignant kidney cysts is increasingly frequent with age, and often leads to #nephrology referral.
Read 52 tweets
Jan 3, 2023
1) Welcome to our #accredited #tweetorial on clinical trial results and emerging data for treatment of Diabetes and CKD #DM in #CKD. I am Brian Rifkin MD, @brian_rifkin, from the Hattiesburg Clinic. #Nephtwitter #Medtwitter #FOAMed
2) This #accredited #tweetorial series on #kidneydisease #CKD is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance. It is not intended for US- or UK-based HCPs. Accreditation statement & faculty disclosures at ckd-ce.com/disclosures/.
3) This activity is accredited for #physicians #physicianassociates #nurses #NPs #pharmacists. Prior programs in this series, still eligible for CE/#CME, can be accessed at ckd-ce.com. FOLLOW US to learn from expert faculty!
Read 41 tweets
Oct 18, 2022
1) Welcome to this new #accredited #tweetorial on “Strategies to Apply Current Clinical Trial Data for SGLT2i to Reduce the Progression of CKD,” authored by our ⭐️tweetorialist Edgar V. Lerma 🇵🇭 @edgarvlermamd Image
2) This program is #accredited for CE/#CME #physicians #physicianassociates #nurses #pharmacists #nursepractitioners & is supported by an educational grant from the Boehringer Ingelheim Pharmaceuticals Inc and Eli Lilly Company. It is intended for healthcare professionals.
3) Faculty disclosures and statement of accreditation are provided at ckd-ce.com/disclosures/. Please FOLLOW @ckd_ce (& @cardiomet_CE!) so you don't miss ANY of our unique serialized #tweetorials, always 🆓, always from expert authors! Prior programs at ckd-ce.com/category/dkd/ .
Read 26 tweets
Sep 13, 2022
1) Welcome to a new #accredited (0.75h CE/#CME) #tweetorial on challenging case presentations for pts with #cardiometabolic disease, #CaReMe #FOAMed.
Our expert author is Claire Davies. @claireyrivs is a specialist diabetes & endocrinology #pharmacist working in Gateshead in 🇬🇧. Image
2) She is a member of UKCPA Diabetes & Endocrinology committee @UKCPADiabetes & works across #diabetes, #endocrinology, & emergency/acute care in Secondary Care. She is currently involved in development of regional guidelines & education to support medicines optimisation for PLWD
3a) This program is intended for healthcare professionals and is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly Company.
Read 36 tweets
Sep 7, 2022
1) Welcome to our new #accredited #tweetorial on the Pathophysiology of #DKD in #T2D: Traditional Teaching and New Insights. Our expert author is Hans-Joachim Anders, MD, @hjanders_hans from @LMU_Uniklinikum of @LMU_Muenchen
2) This #accredited #tweetorial series on the foundations of #kidneydisease #DKD through the lens of #T2D is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance and is intended for healthcare providers.
3) This activity is accredited for #physicians #physicianassociates #nurses #NPs #pharmacists. Past programs still eligible for credit can be found at ckd-ce.com. Faculty disclosures & accreditation statement are at ckd-ce.com/disclosures/. FOLLOW US!
Read 48 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(